1. Masslo Anderson J. Biotech Discovers the Shark. MD Magazine 1993;37:43.
2. Moss RW. Cancer Therapy: The Independent Consumers Guide to Non-Toxic Treatment & Prevention. New York: Equinox Press, 1992.
3. Pettit GR, Ode RH. Antineoplastic agents L: isolation and characterization of sphyrnastatins 1 and 2 from the hammerhead shark Sphyrna lewini . J Pharm Sci 1977:66:757. PubMed
4. Neame PJ, et al. Primary structure of a protein isolated from reef shark (Carcharhinus springeri) cartilage that is similar to the mammalian C-type lectin homolog, tetranectin. Protein Sci 1992:1(1):161. PubMed
5. Moore KS, et al. Squalamine: an aminosterol antibiotic from the shark. Proc Nat Acad Sci USA 1993;90(4):1354. PubMed
6. Hunt TJ, Connelly JF. Shark cartilage for cancer treatment. Am J Health-Syst Pharm 1995;52:1756. PubMed
7. Berbari P, Thibodeau A, Germain L, et al. Antiangiogenic effects of the oral administration of liquid cartilage extract in humans. J Surg Res . 1999;87:108-113. PubMed
8. Falardeau P, Champagne P, Poyet P, Hariton C, Dupont E. Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials. Semin Oncol . 2001;28:620-625. PubMed